Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Search Posts
Op-Eds
Precaution without Principle
The European Parliament voted earlier this summer to change the way it regulates gene-splicing, or genetic modification (GM) technology, possibly opening the way…
Products
September Edition of Monthly Planet
Full Document Available in PDF Articles in this edition: “The…
Op-Eds
EU Over-REACH
The latest mutation of the Precautionary Principle–which would heavily regulate, if not prohibit, any product, technology or activity that is in any way incomplete–is…
Op-Eds
Europe’s REACH Exceeds Its Scientific Grasp
European regulatory officials have raised hostility to technological innovation to an art form. Their current medium of choice is the Precautionary Principle, which holds…
Op-Eds
Stockholm Syndrome
The Stockholm Convention on Persistent Organic Pollutants (POPs) is a United Nations Environment Programme Convention, which bans or regulates industrial chemicals and pesticides. The…
Op-Eds
Brussels’ Bad Science Will Cost the World Dear
Regulatory officials in the European Union seem to be ignorant of the rule of holes: when you are in one, stop digging. Numerous analyses…